ACE Insertion/Deletion Genotypes and Angiotensin II Receptor Blockade in Diabetic Nephropathy: Is there a light at the end of the tunnel?

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

Kidney International ◽

10.1111/j.1523-1755.2005.00394.x ◽

2005 ◽

Vol 68 (1) ◽

pp. 193-205 ◽

Cited By ~ 104

Author(s):

Kasper Rossing ◽

Harald Mischak ◽

Hans-Henrik Parving ◽

P.E.R. K. Christensen ◽

Michael Walden ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Polypeptide Patterns ◽

Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade

PLoS ONE ◽

10.1371/journal.pone.0042623 ◽

2012 ◽

Vol 7 (8) ◽

pp. e42623 ◽

Cited By ~ 20

Author(s):

Ina M. Ott ◽

Markus L. Alter ◽

Karoline von Websky ◽

Axel Kretschmer ◽

Oleg Tsuprykov ◽

...

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Guanylate Cyclase ◽

Knockout Mice ◽

Soluble Guanylate Cyclase ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Stimulation Of

What does the future hold? ACE inhibition, angiotensin II receptor blockade, and diabetic nephropathy

Blood Pressure Monitoring ◽

10.1097/00126097-200010002-00002 ◽

2000 ◽

Vol 5 (Sup 2) ◽

pp. S3-S6 ◽

Cited By ~ 2

Author(s):

Norman K. Hollenberg

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Ace Inhibition ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

The Future ◽

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70441-3 ◽

2006 ◽

Vol 2006 ◽

pp. 208-209

Author(s):

R. Garrick

Keyword(s):

Blood Pressure ◽

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Blood Pressure Control ◽

Pressure Control ◽

Clinical Implications ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Irbesartan Diabetic Nephropathy Trial

Ace Inhibition, Angiotensin II Receptor Blockade, and Diabetic Nephropathy

The Kidney and Hypertension in Diabetes Mellitus ◽

10.1007/978-1-4615-4499-9_32 ◽

2000 ◽

pp. 417-422

Author(s):

Norman K. Hollenberg

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Ace Inhibition ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

ACE Inhibition, Angiotensin II Receptor Blockade, and Diabetic Nephropathy

The Kidney and Hypertension in Diabetes Mellitus ◽

10.1007/978-1-4757-6752-0_39 ◽

1998 ◽

pp. 393-397

Author(s):

Norman K. Hollenberg

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Ace Inhibition ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

Kidney International ◽

10.1046/j.1523-1755.2000.00880.x ◽

2000 ◽

Vol 57 (2) ◽

pp. 601-606 ◽

Cited By ~ 188

Author(s):

Steen Andersen ◽

Lise Tarnow ◽

Peter Rossing ◽

Birgitte V. Hansen ◽

Hans-Henrik Parving

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Diabetic Patients ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Type 1 Diabetic Patients

Angiotensin II receptor blockade in diabetic nephropathy

American Journal of Hypertension ◽

10.1016/s0895-7061(02)03152-7 ◽

2003 ◽

Vol 16 (1) ◽

pp. 100-101 ◽

Cited By ~ 5

Author(s):

E Lewis

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy

Journal of the American Society of Nephrology ◽

10.1097/01.asn.0000054495.96193.bf ◽

2003 ◽

Vol 14 (4) ◽

pp. 992-999 ◽

Cited By ~ 144

Author(s):

P. Jacobsen

Keyword(s):

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Ace Inhibition ◽

Additive Effect ◽

Diabetic Patients ◽

Type I ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations

Journal of the American Society of Nephrology ◽

10.1681/asn.2004110919 ◽

2005 ◽

Vol 16 (10) ◽

pp. 3027-3037 ◽

Cited By ~ 241

Author(s):

Marc A. Pohl ◽

Samuel Blumenthal ◽

Daniel J. Cordonnier ◽

Fernando De Alvaro ◽

Giacomo DeFerrari ◽

...

Keyword(s):

Blood Pressure ◽

Diabetic Nephropathy ◽

Angiotensin Ii ◽

Blood Pressure Control ◽

Pressure Control ◽

Clinical Implications ◽

Receptor Blockade ◽

Angiotensin Ii Receptor ◽

Irbesartan Diabetic Nephropathy Trial